Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The CD47 molecule pseudogene (ENSG00000254890) is a region of DNA that closely resembles the functional CD47 gene but contains mutations or disruptions that prevent it from producing a functional protein. Pseudogenes like this arise throughout evolution via gene duplication, retrotransposition, or gene disabling mutations[3][7]. While the parent CD47 gene encodes a widely-expressed membrane receptor involved in immune modulation (notably as a target for cancer immunotherapy), the pseudogene is not expressed as a functional protein and holds no direct therapeutic, diagnostic, or mechanistic relevance[1][6]. Scientifically, pseudogenes may serve as evolutionary markers or occasionally exert regulatory RNA effects, but no such role is established for the CD47 molecule pseudogene[3][5]. Key distinctions: - The CD47 gene/protein (not the pseudogene) is a validated therapeutic target in oncology and immunology[2][4][6]. - The CD47 molecule pseudogene does *not* encode an active protein, receptor, or therapeutic target, making it unsuitable for drug development or biomarker use[1][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on CD47 molecule pseudogene.